ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+2.4%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$3.92B
AUM Growth
+$60.6M
(+1.6%)
Cap. Flow
+$24.4M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
1,323
New
91
Increased
696
Reduced
400
Closed
115
Top Buys
| 1 |
Health Care Select Sector SPDR Fund
XLV
|
+$86.1M |
| 2 |
Energy Select Sector SPDR Fund
XLE
|
+$77M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$51.9M |
| 4 |
iShares Select Dividend ETF
DVY
|
+$42.1M |
| 5 |
Eli Lilly
LLY
|
+$26.5M |
Top Sells
| 1 |
SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
|
+$67.2M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$57.3M |
| 3 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$49.6M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$48.9M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$40.4M |
Sector Composition
| 1 | Technology | 21.96% |
| 2 | Energy | 13.21% |
| 3 | Healthcare | 9.34% |
| 4 | Industrials | 7.71% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Aris Water Solutions
ARIS
$788M
| $199K | 0.01% |
12,670
+7,765
| +158% | +$122K |
|
877
Syndax Pharmaceuticals
SNDX
$1.41B
| $197K | 0.01% |
9,595
-2,985
| -24% | -$61.3K |
|
878
Tyra Biosciences
TYRA
$665M
| $196K | ﹤0.01% |
12,245
-3,808
| -24% | -$60.9K |
|
879
Nuvalent
NUVL
$5.93B
| $195K | ﹤0.01% |
2,570
-798
| -24% | -$60.5K |
|
|
BCYC
880
Bicycle Therapeutics
BCYC
$487M
| $192K | ﹤0.01% |
9,474
-2,947
| -24% | -$59.6K |
|
881
Rollins
ROL
$28.2B
| $190K | ﹤0.01% |
3,891
+922
| +31% | +$45K |
|
882
BioNTech
BNTX
$25.1B
| $188K | ﹤0.01% |
2,340
-727
| -24% | -$58.4K |
|
883
Xencor
XNCR
$606M
| $187K | ﹤0.01% |
9,866
-3,068
| -24% | -$58.1K |
|
884
Prelude Therapeutics
PRLD
$68.5M
| $186K | ﹤0.01% |
48,727
-15,160
| -24% | -$57.8K |
|
885
Arcus Biosciences
RCUS
$1.22B
| $181K | ﹤0.01% |
11,863
-3,690
| -24% | -$56.2K |
|
886
Genmab
GMAB
$17.6B
| $180K | ﹤0.01% |
7,174
-2,230
| -24% | -$56K |
|
887
Dick's Sporting Goods
DKS
$20.7B
| $177K | ﹤0.01% |
+825
| New | +$177K |
|
888
Y-mAbs Therapeutics
YMAB
$390M
| $175K | ﹤0.01% |
14,489
-4,507
| -24% | -$54.4K |
|
889
Relay Therapeutics
RLAY
$710M
| $173K | ﹤0.01% |
26,600
-8,276
| -24% | -$54K |
|
890
Arcellx
ACLX
$4.31B
| $172K | ﹤0.01% |
3,125
-971
| -24% | -$53.6K |
|
891
Zymeworks
ZYME
$1.24B
| $172K | ﹤0.01% |
20,180
-6,276
| -24% | -$53.4K |
|
892
IDEAYA Biosciences
IDYA
$2.18B
| $170K | ﹤0.01% |
4,851
-1,509
| -24% | -$53K |
|
|
IPHA
893
Innate Pharma
IPHA
$188M
| $167K | ﹤0.01% |
86,237
-26,833
| -24% | -$52.1K |
|
|
EXAI
894
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $167K | ﹤0.01% |
32,680
-10,167
| -24% | -$51.9K |
|
|
SWTX
895
DELISTED
SpringWorks Therapeutics
SWTX
| $165K | ﹤0.01% |
4,392
-1,367
| -24% | -$51.5K |
|
896
Kymera Therapeutics
KYMR
$3.3B
| $164K | ﹤0.01% |
5,502
-1,710
| -24% | -$51K |
|
897
Schrodinger
SDGR
$1.38B
| $163K | ﹤0.01% |
8,440
-2,625
| -24% | -$50.8K |
|
898
Sutro Biopharma
STRO
$82.2M
| $159K | ﹤0.01% |
54,195
-16,861
| -24% | -$49.4K |
|
899
Texas Pacific Land
TPL
$21.6B
| $159K | ﹤0.01% |
216
+21
| +11% | +$15.4K |
|
900
CubeSmart
CUBE
$9.49B
| $158K | ﹤0.01% |
3,492
+865
| +33% | +$39.1K |
|